Metaplastic breast cancer. A case series

Alba  Capobianco; Alfredo  Tartarone; Giuseppe  Patitucci; Giulia  Vita; Giuseppe  Torre; Giuseppina  Gallucci; Loredana  Lapadula; Nicola  Sisti; Leuconoe  Sisti

1 Sep 2021Case Report

Alba Capobianco ¹Alfredo Tartarone ²Giuseppe Patitucci ³Giulia Vita ³Giuseppe Torre ⁴Giuseppina Gallucci ⁵Loredana Lapadula ⁶Nicola Sisti ⁷Leuconoe Sisti ⁸

Affiliations

Article Info

¹ Multidisciplinary Cancer Teams Unit-Department Health Directorate, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

² Department of Onco-Hematology, Division of Medical Oncology, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

³ Department of Pathology, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

⁴ Department of Surgical Oncology, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

⁵ Unit of Cardiology, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

⁶ Radiation Oncology Department, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

⁷ Pharmacist, Pharmacovigilance Manager, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

⁸ Department of Public Health-Catholic University of the Sacred Heart, Rome. Italy

Abstract

Special type breast cancers display a wide range of different histological types in which clear recommendations on clinical and therapeutic management still lack and most of the information available derive from case report and case studies. In particular metaplastic breast cancer (MBC) is a rare and aggressive type of breast cancer accounting for around 1% of breast malignancies. We reported our experience in the management of five patients with MBC diagnosed and treated in our institution during the last few years (2016-2020).

Keywords

Metaplastic breast cancer
Special type breast cancers